CAS: 397308-78-0; 4-Hydroxy-2-(Methylthio)Pyrimidine-5-Carboxylic Acid

该化合物是一种环状体化合物,其特征是其火林结构,包括一个甲基硫基环组和一个碳球酸功能组.该化合物具有六人环,具有两个氮原子,有助于其基本性和潜在再活动.甲基硫基化合物组的存在增强了其在有机溶剂中的溶性,并可能影响其生物活动.氨基酸组提供了酸性,允许生物化学途径中的潜在互动.该化合物可能展示各种药用活动,使其对药用化学感兴趣.其结构特征表明药物开发的潜在应用,特别是针对特定生物途径.此外,该化合物的稳定性和再活性可能受到诸如pH和温度等环境因素的影响,这些环境因素是其实际应用中的重要考虑因素.

结构式图片

相似化合物

84332-06-9 84936-81-2 4774-35-0

上下游产品

CAS号5909-24-0 4-氯-2-甲硫基嘧啶-5-羧酸乙酯 | CAS号10519-96-7 三甲基硅醇钾

合成工艺路线路线简述

  • 合成目标产物 4-Hydroxy-2-(Methylthio)Pyrimidine-5-Carboxylic Acid 主要起始原料 1,4-Dihydro-2-(Methylthio)-4-Oxo-5-Pyrimidine-Carboxylate Acid Ethyl Ester
  • (文献来源)合成步骤主要原料 1,4-Dihydro-2-(Methylthio)-4-Oxo-5-Pyrimidine-Carboxylate Acid Ethyl Ester
📜4-氯-2-甲硫基嘧啶-5-羧酸乙酯置于水,Sodium Hydroxide体系中,用 乙醇 作为反应溶剂,化学反应 2.0H,以75%的收率获得产物4-羟基-2-(甲硫基)嘧啶-5-羧酸
参考文献: Heterocyclic Compounds And Uses Thereof[fr] Composés Hétérocycliques Et Leurs Utilisations
标题: Heterocyclic Compounds And Uses Thereof[fr] Composés Hétérocycliques Et Leurs Utilisations
摘要:提供了一种作为weel抑制剂的杂环化合物.这些化合物可能用作治疗疾病的治疗剂,特别是在肿瘤学中可能具有特殊用途.

海关参考信息

专利信息


专利号:US-2004033967-A1
优先权日:2000-08-30
标题:Alkylated hexitol nucleoside analogues and oligomers thereof
发明人:VAN AERSCHOT ARTHUR; HERDEWIJN PIET
摘要:The present invention is directed to nucleoside analogues with as substitute for the sugar part a 1,5-anhydrohexitol moiety, doexygenated and substituted with a nucleobase at the 2-position, of which the hexitorl ring is further substituted with at least one alkoxy substituent at the 3-position or at the 1-position, and to oligonucleotides wherein at least some of the nucleotides are part of the afore mentioned hexitol nucleoside analogues and exhibit sequence-specific hydridization to complementary sequences of nucleic acids, and maintaining or improving the hybridisation strength. The invention further relates to nucleoside analogues with a 1,5-anhydrohexitol moiety as the sugar part, deoxygenated and substituted with a nucleobase at the 2-position, of which the hexitol ring is substituted with a methoxy substituent at the 1-position, having at the same time either a hydroxy or an alkoxy group at the 3-position, or having a 3-deoxygenated position. The inclusion of one or more of the afore mentioned hexitol nucleoside analogues in oligonucleotides provides, inter alia, either for improved binding or for maintained binding of these oligonucleotides to a complementary strand. This invention further relates to the chemical synthesis of these oligomers which are useful diagnostics, therapeutics and as research agents.

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


参考文献:10.1021/acs.jmedchem.1c00605
摘要:Nowak RP, Tumber A, Hendrix E, Ansari MSZ, Sabatino M, Antonini L, Andrijes R, Salah E, Mautone N, Pellegrini FR, Simelis K, Kawamura A, Johansson C, Passeri D, Pellicciari R, Ciogli A, Del Bufalo D, Ragno R, Coleman ML, Trisciuoglio D, Mai A, Oppermann U, Schofield CJ, Rotili D. First-in-Class Inhibitors of the Ribosomal Oxygenase MINA53. J. Med. Chem. 2021 Nov 29;64(23):17031–50. doi: 10.1021/acs.jmedchem.1c00605.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知